Illumina, Inc. (ILMN)
NASDAQ: ILMN · IEX Real-Time Price · USD
114.49
-1.30 (-1.12%)
At close: Jul 19, 2024, 4:00 PM
115.42
+0.93 (0.81%)
Pre-market: Jul 22, 2024, 7:10 AM EDT
Illumina Market Cap
Illumina has a market cap or net worth of $18.24 billion as of July 22, 2024. Its market cap has decreased by -36.78% in one year.
Market Cap
18.24B
Enterprise Value
19.32B
1-Year Change
-36.78%
Ranking
Category
Stock Price
$114.49
Market Cap Chart
Since July 28, 2000, Illumina's market cap has increased from $1.24B to $18.24B, an increase of 1,376.18%. That is a compound annual growth rate of 11.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 18.24B | -17.52% |
Dec 29, 2023 | 22.11B | -30.48% |
Dec 30, 2022 | 31.81B | -46.51% |
Dec 31, 2021 | 59.46B | 10.08% |
Dec 31, 2020 | 54.02B | 10.77% |
Dec 31, 2019 | 48.77B | 10.61% |
Dec 31, 2018 | 44.09B | 38.21% |
Dec 29, 2017 | 31.90B | 69.60% |
Dec 30, 2016 | 18.81B | -33.07% |
Dec 31, 2015 | 28.10B | 7.21% |
Dec 31, 2014 | 26.21B | 87.51% |
Dec 31, 2013 | 13.98B | 104.45% |
Dec 31, 2012 | 6.84B | 84.71% |
Dec 30, 2011 | 3.70B | -53.27% |
Dec 31, 2010 | 7.92B | 106.38% |
Dec 31, 2009 | 3.84B | 19.06% |
Dec 31, 2008 | 3.22B | -0.56% |
Dec 31, 2007 | 3.24B | 77.31% |
Dec 29, 2006 | 1.83B | 215.10% |
Dec 30, 2005 | 580.20M | 60.72% |
Dec 31, 2004 | 361.00M | 55.87% |
Dec 31, 2003 | 231.60M | 111.51% |
Dec 31, 2002 | 109.50M | -71.10% |
Dec 31, 2001 | 378.90M | -26.13% |
Dec 29, 2000 | 512.90M | -58.49% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Zimmer Biomet Holdings | 22.73B |
STERIS | 22.17B |
BioNTech SE | 20.32B |
Teva Pharmaceutical | 19.04B |
Align Technology | 18.94B |
Hologic | 18.23B |
Genmab | 18.08B |
The Cooper Companies | 18.07B |